Skip to main content
Springer Nature Link
Log in

Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Wang Y, Jadhav PR, Lala M, Gobburu JV. Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies. J Clin Pharmacol. 2012;52:1601–6.

    Article  CAS  PubMed  Google Scholar 

  2. Leroux S, Turner MA, Barin-Le Guellec C, Hill H, van den Anker JN, Kearns GL, On behalf of the TINN and GRiP Consortia, et al. Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design. Clin Pharmacokinet. 2015. doi:10.1007/s40262-015-0291-1.

    PubMed  Google Scholar 

  3. Zhao W, Hill H, Le Guellec C, Neal T, Mahoney S, Paulus S, On behalf of the TINN consortium, et al. Population pharmacokinetics of ciprofloxacin in neonates and young infants less than 3 months of age. Antimicrob Agents Chemother. 2014;58(11):6572–80.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Rees VE, Bulitta JB, Nation RL, Tsuji BT, Sörgel F, Landersdorfer CB. Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa. J Antimicrob Chemother. 2015;70(3):818–26.

    Article  CAS  PubMed  Google Scholar 

  5. Mentre F, Dubruc C, Thenot JP. Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children. J Pharmacokinet Pharmacodyn. 2001;28(3):299–319.

    Article  CAS  PubMed  Google Scholar 

  6. Lutsar I, Trafojer UM, Heath PT, Metsvaht T, Standing J, Esposito S, On behalf of the NeoMero Consortium, et al. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials. 2011;12:215.

Download references

Author information

Authors and Affiliations

  1. Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK

    Joseph F. Standing

  2. Department of Anaesthesiology, University of Auckland, Auckland, New Zealand

    Brian J. Anderson

  3. Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand

    Nicholas H.G. Holford

  4. Department of Microbiology, University of Tartu, Tartu, Estonia

    Irja Lutsar

  5. Tartu University Clinic, Tartu, Estonia

    Tuuli Metsvaht

Authors
  1. Joseph F. Standing
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Brian J. Anderson
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nicholas H.G. Holford
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Irja Lutsar
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Tuuli Metsvaht
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Joseph F. Standing.

Ethics declarations

No funding was received in the preparation of this manuscript. JS, BA, NH, IL, and MT have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Standing, J.F., Anderson, B.J., Holford, N.H. et al. Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design. Clin Pharmacokinet 54, 1287–1288 (2015). https://doi.org/10.1007/s40262-015-0344-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-015-0344-5

Keywords